Accordingly, the expression of phosphorylated STAT3 (active STAT3) was decreased in dysplastic nodules compared with chronic hepatitis tissues and completely lost in hepatocellular carcinoma tissue (Table 4), which is similar to the pattern of SHP2 expression. The gene discussed is STAT3; the disease is hepatocellular carcinoma.